ArticleJBMR plus2024
Romosozumab added to ongoing denosumab in postmenopausal osteoporosis, a prospective observational study.
Giovanni Adami et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
25 papers cite it
this papertrialcites it